Aptevo Therapeutics Inc.APVONASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P0
Near historical low
vs 5Y Ago
-5.8x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2024-102.77%
202344.20%
20223.03%
202126.06%
202030.83%
201917.58%
2018-23.69%
2017-12.78%
201624.40%
2015-3.73%